Endo, Others Look To Pare State Claims In Lidoderm MDL
By Melissa Lipman ( February 3, 2015, 7:45 PM EST) -- Endo Pharmaceuticals Inc. and two other drugmakers have pushed a California federal court overseeing the Lidoderm multidistrict litigation to pare down state antitrust claims from updated complaints end payors and the Government Employees Health Association filed over an alleged pay-for-delay deal for the pain medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.